Introduction
Jaloukas have been part of the therapeutic arsenal since ancient times. The first written records of leech therapy in Egypt date back over 3500 years, while evidence of its therapeutic use by Greek, Roman, and Indian civilizations dates back approximately 2000 years. Jaloukavacharana, a method of Raktamokshana, is described in the Sushruta Samhita and Astanga Hridaya. Leeches are indicated for conditions such as Twakroga, Raktajaroga, Dustavrana, Arsha, Vidradhi, Mukhadushika, Indralupta, and others.[1,2] Jalouka is considered an Anushastra and has been used in parasurgical procedures.[3,4] Sushruta, the first surgeon, provided a detailed explanation of Sandhanakarma, a term referring to joining, union, restoration, and repair.[5]
Sandhanakarma is mentioned in various contexts by Acharya Sushruta, such as in wound healing, fractures, Arsha, intestinal anastomosis, and reconstructive procedures for the ear, lip, and nose. The reconstruction of the ear and nose was extensively described by Sushruta[6], and his procedure for Nasasandhana remains in practice today, forming the foundation for the Indian approach to rhinoplasty. Sandhanakarma can be compared to modern plastic and reconstructive surgery. Today, medicinal leeches (Hirudo medicinalis) are used in a practice known as Hirudotherapy. They are widely applied in plastic and reconstructive surgery. Despite significant advancements in reconstructive surgery, especially microsurgery, venous congestion in transplanted or reimplanted tissues remains a common and challenging complication. Medicinal leeches have been used to salvage free flaps, pedicled flaps, nippleareolar complexes, and in the replantation of fingers, ears, lips, noses, penises, and other organs affected by venous congestion[7], a condition that occurs when venous outflow cannot keep up with arterial inflow[8], leading to cell death, tissue necrosis, and flap loss. In 1960, Deganc and Zdravic performed the first leech treatment for a congested flap.[9]
In July 2004, the FDA approved leeches as a medicinal device for use in plastic and reconstructive surgery.[10] This review aims to explore the role of Jaloukavacharana in Sandhanakarma.
Materials and Methods
A systematic review of the literature was performed using the PubMed, EmBASE, and ResearchGate platforms. The following keywords were used in the search: "leeches" or "Jaloukavacharana" or "leech therapy" and "flap" or "plastic surgery" or "Sandhanakarma." Ayurvedic classics and relevant books are also referred. This approach allowed me to preselect relevant articles. The data collected focused on the role of leech therapy in plastic surgery.
Results
In plastic and reconstructive surgery, leeches primarily help alleviate venous congestion in compromised flaps. Postoperatively, the success of the flap depends on careful monitoring for vascular issues, with venous thrombosis being both the most common and rapidly damaging complication. This study confirms that Jaloukavacharana provides excellent and predictable healing for compromised flaps, leading to successful graft acceptance in plastic and reconstructive surgeries. Medicinal leeches offer a non-surgical solution for plastic surgery patients experiencing venous congestion. This is primarily due to the key properties of medicinal leeches, such as their blood-letting action during active blood suction, the passive oozing of the wound for 1-2 days, and the injection of biologically active substances that promote healing.
Discussion
After reconstructive surgery, flaps or reimplanted tissues may experience venous congestion. This occurs when the small, thin-walled veins involved in microsurgical procedures are unable to effectively carry blood away from the surgical site. As a result, blood pools in the veins and cannot return to the heart and lungs for re-oxygenation. Clinical signs of venous congestion include cyanosis or a dusky coloration, increased turgor, a cool touch, brisk capillary refill, and rapid dermal bleeding[11](Fig. 1). If left untreated, stagnant blood leads to the accumulation of carbon dioxide, which can ultimately result in tissue death. In such cases, Jaloukavacharana may be recommended for optimal recovery. Therefore, preventing flap necrosis, the most common complication of venous congestion, becomes a key indication for leech therapy.